HWAM
ICPT
Hennion & Walsh Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-46,315
| Closed | -$859K | – | 887 |
|
|
2023
Q3 | $859K | Buy |
46,315
+21,878
| +90% | +$406K | 0.05% | 394 |
|
|
2023
Q2 | $270K | Buy |
+24,437
| New | +$270K | 0.02% | 687 |
|
|
2022
Q4 | – | Sell |
-76,984
| Closed | -$1.07M | – | 821 |
|
|
2022
Q3 | $1.07M | Sell |
76,984
-4,349
| -5% | -$60.7K | 0.07% | 306 |
|
|
2022
Q2 | $1.12M | Sell |
81,333
-27,651
| -25% | -$382K | 0.07% | 288 |
|
|
2022
Q1 | $1.77M | Sell |
108,984
-4,264
| -4% | -$69.4K | 0.09% | 240 |
|
|
2021
Q4 | $1.85M | Sell |
113,248
-23,472
| -17% | -$382K | 0.09% | 246 |
|
|
2021
Q3 | $2.03M | Sell |
136,720
-4,038
| -3% | -$60K | 0.11% | 239 |
|
|
2021
Q2 | $2.81M | Buy |
140,758
+5,544
| +4% | +$111K | 0.15% | 192 |
|
|
2021
Q1 | $3.12M | Buy |
+135,214
| New | +$3.12M | 0.19% | 147 |
|